Black Hawk Acquisition CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
DEFA14A: Black Hawk Acquisition Seeks Shareholder Approval for Business Combination Deadline Extension
Black Hawk Acquisition Corporation is seeking shareholder approval to extend the deadline for completing its initial business combination from June 22, 2025, to December 22, 2026, requiring monthly deposits into its trust account.
NASDAQ
Black Hawk Acquisition Corporation has filed a supplement to its definitive proxy statement, seeking shareholder approval to extend its business combination deadline to December 22, 2026, and modifying the terms of its Trust Agreement Amendment Proposal.
NASDAQ
Black Hawk Acquisition Corporation has filed a supplement to its proxy statement, seeking shareholder approval to extend its business combination deadline to December 22, 2026, while committing to waive certain dissolution expenses, provide transparency on trust account contributions, and maintain extension terms.
NASDAQ
Black Hawk Acquisition Corporation is seeking shareholder approval to extend its business combination deadline by 18 months to December 22, 2026, to facilitate the completion of its proposed merger with Vesicor Therapeutics, Inc.
NASDAQ
Black Hawk Acquisition Corporation, a SPAC, is calling an Extraordinary General Meeting on June 20, 2025, to seek shareholder approval for an 18-month extension to its business combination deadline, aiming to complete its merger with Vesicor Therapeutics or find an alternative target.